KDIGO guidelines include FILSPARI for IgA nephropathy treatment Sep 26, 2025 07:02AM
Travere Therapeutics (TVTX) and CSL Vifor Announce Standard EU Approval of FILSPARI (sparsentan) for IgA Nephropathy Apr 29, 2025 07:07AM